Cargando…
Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients
Sclerostin and dickkopf-1 (DKK1) played a role in the development of cardiovascular diseases and arterial stiffness in chronic kidney disease (CKD) patients but with controversial results of patients in end-stage renal disease (ESRD) including hemodialysis (HD) and peritoneal dialysis (PD). This stu...
Autores principales: | Wu, Chun-Feng, Hou, Jia-Sian, Wang, Chih-Hsien, Lin, Yu-Li, Lai, Yu-Hsien, Kuo, Chiu-Huang, Liou, Hung-Hsiang, Tsai, Jen-Pi, Hsu, Bang-Gee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068530/ https://www.ncbi.nlm.nih.gov/pubmed/32075016 http://dx.doi.org/10.3390/ijerph17041230 |
Ejemplares similares
-
Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients
por: Kuo, Chiu-Huang, et al.
Publicado: (2018) -
The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis
por: Lin, Lin, et al.
Publicado: (2019) -
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
por: Chang, Yu-Chi, et al.
Publicado: (2018) -
Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients
por: Hou, Jia-Sian, et al.
Publicado: (2020) -
Serum P-Cresyl Sulfate Is a Predictor of Central Arterial Stiffness in Patients on Maintenance Hemodialysis
por: Lai, Yu-Hsien, et al.
Publicado: (2019)